![]() ![]() These MRA treatments were used in 34% of patients with controlled aRH, but only 11% of patients with uncontrolled aRH. ![]() Through their analysis, investigators also learned that patients with well-managed aRH were more likely to be treated with a commonplace medication called mineralocorticoid receptor antagonist, or MRA. The more we can study the disease and its lingering effects, the better we will understand its lasting impact on our health.”Īnyone experiencing these symptoms may call the Smidt Heart Institute at 31 to request an appointment at the new cardiac COVID-19 clinic.Novel research from investigators in the Smidt Heart Institute at Cedars-Sinai, published today in the peer-reviewed journal Hypertension, found that aRH prevalence was lower in a real-world sample than previously reported, but still relatively frequent - affecting nearly 1 in 10 hypertensive patients. “As of today, we are only seeing the tip of the iceberg. “These studies give us reason to believe the number of COVID-19 survivors who end up with long-lasting heart issues is greater than we ever imagined,” Marban said. The studies, published in the journal JAMA Cardiology, suggest that even asymptomatic cases in young people can cause inflammation and increased fibrosis in the heart - both of which are associated with heart failure and sudden death. While these patients were not studied prior to contracting COVID-19, so the issues might not be related, the frequency of abnormal findings seems much greater than it is in the general population, according to Marban. Three recent scientific studies conducted outside of Cedars-Sinai point to patients, including athletes and others who didn’t experience symptoms, having detectable issues with their hearts after surviving the virus. Marban said that what is known about the effects of the virus on the heart raises concerns. Until physicians know more about what makes the virus so debilitating for some patients while others don’t experience any symptoms, Singh says the most effective weapon remains wearing masks, as well as social distancing and frequently washing hands. “However, this immune response tends to occur only in the severely ill.” “As of now, we understand the virus can cause an inflammatory response and clotting in small and large blood vessels, ultimately affecting both the heart and cardiovascular system,” Singh said. Siddharth Singh, director of the new heart clinic, says there is still a lot to learn about the virus. When it comes to the “why” of COVID-19 affecting the heart, Dr. Cedars-Sinai investigators have initiated more than 80 studies and clinical trials to better understand the impacts and risks of the disease.Īlthough not all COVID-19 survivors will experience heart complications or damage, there are high-risk groups as well as telltale symptoms that warrant a call or visit to a doctor or medical clinic. In addition to the post-COVID-19 heart program, Cedars-Sinai is set to open other specialized clinics to treat and study other long-term health problems associated with the coronavirus, including lung damage and cognitive issues. “As an institute, we are committed to understanding how COVID-19 is impacting all survivors.” Eduardo Marban, executive director of the Smidt Heart Institute. ![]() “This first-of-its-kind program created uniquely for COVID-19 survivors will benefit patients and aid ongoing research,” said Dr. The move comes after multiple studies showing that even asymptomatic cases of the virus in young people can cause conditions associated with heart failure. 9 that it will launch a specialized cardiac clinic to treat heart damage in COVID-19 survivors. The Smidt Heart Institute at Cedars-Sinai announced Monday, Nov. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |